Fol. Biol. 2013, 59, 181-187
https://doi.org/10.14712/fb2013059050181
Serum Levels of Matrix Metalloproteinases 2 and 9 in Patients with Acute Myocardial Infarction
Crossref Cited-by Linking
- Sullivan Holly L., Gianneschi Nathan C., Christman Karen L.: Targeted nanoscale therapeutics for myocardial infarction. Biomater. Sci. 2021, 9, 1204. <https://doi.org/10.1039/D0BM01677B>
- Luo Shanshan, Hieu Tran Ba, Ma Fenfen, Yu Ying, Cao Zhonglian, Wang Minjun, Wu Weijun, Mao Yicheng, Rose Peter, Law Betty Yuen-Kwan, Zhu Yi Zhun: ZYZ-168 alleviates cardiac fibrosis after myocardial infarction through inhibition of ERK1/2-dependent ROCK1 activation. Sci Rep 2017, 7. <https://doi.org/10.1038/srep43242>
- Bronisz El\u017cbieta, Kurkowska-Jastrz\u0119bska Iwona: Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development. Mediators of Inflammation 2016, 2016, 1. <https://doi.org/10.1155/2016/7369020>
- Cheng Nan, Wang Honghao, Dong Jianjian, Pan Suyue, Wang Xun, Han Yongsheng, Han Yongzhu, Yang Renmin: Elevated serum brain natriuretic peptide and matrix metalloproteinases 2 and 9 in Wilson\u2019s disease. Metab Brain Dis 2015, 30, 1087. <https://doi.org/10.1007/s11011-015-9685-x>